THE SINGLE BEST STRATEGY TO USE FOR DICLOFENAC SODIUM

Gastrointestinal (GI): NSAIDs that block COX-1 activity have correlations with GI issues as a result of inhibition on the synthesis of gastroprotective brokers which include PGE2 and other prostaglandins. This inhibition results in reduced mucin creation by gastric epithelial cells, a lot less bicarbonate secretion, and fewer epithelial mobile turn